| AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer A Aytatli, N Barlak, F Sanli, HO Caglar, B Gundogdu, A Tatar, M Ittmann, ... Cellular Oncology, 1-16, 2022 | 19 | 2022 |
| ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer N Barlak, O Capik, F Sanli, A Kilic, A Aytatli, A Yazici, S Ortucu, M Ittmann, ... Cell Biology International 44 (1), 242-252, 2020 | 19 | 2020 |
| The effects of Daucus carota extract against PC3, PNT1a prostate cells, acetylcholinesterase, glutathione S‐transferase, and α‐glycosidase; an in vitro–in silico study MN Atalar, A Aras, F Türkan, N Barlak, Ü Yildiko, OF Karatas, MH Alma Journal of Food Biochemistry 45 (12), e13975, 2021 | 18 | 2021 |
| Mode of action of carboplatin via activating p53/miR‐145 axis in head and neck cancers A Kilic, N Barlak, F Sanli, A Aytatli, O Capik, OF Karatas The Laryngoscope 130 (12), 2818-2824, 2020 | 15 | 2020 |
| MicroRNA‐145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells N Barlak, O Capik, A Kilic, F Sanli, A Aytatli, A Yazici, EA Karatas, ... Cell Biology International 45 (5), 1082-1090, 2021 | 12 | 2021 |
| The roles of microRNAs in the stemness of oral cancer cells N Barlak, O Capik, F Sanli, OF Karatas Oral Oncology 109, 104950, 2020 | 12 | 2020 |
| MiR-4484 Acts as a Potential Saliva Biomarker for Early Detection of Peri-implantitis. G Urvasizoglu, A Kilic, N Barlak, M Gundogdu, OF Karatas International Journal of Oral & Maxillofacial Implants 36 (1), 2021 | 7 | 2021 |
| Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers OF Karatas, O Capik, N Barlak, E Aydin Karatas Head & Neck 43 (1), 288-302, 2021 | 6 | 2021 |
| Current cancer stem cell biomarkers in laryngeal cancer OF Karatas, N Barlak, H Sahin, H Aydin The European Research Journal 3 (3), 200-206, 2017 | 3 | 2017 |
| Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep-2 to 5-Fluorouracil N Barlak, F Sanli, O Capik, E Tuysuz, E Aydın Karatas, H Turkez, ... Clinical Cancer Drugs 7 (1), 16-24, 2020 | 2 | 2020 |
| The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells F Şanlı, N Barlak, A Kılınç, Ö Çapık, A Aytatlı, OF Karatas The European Research Journal 6 (5), 380-387, 2020 | 2 | 2020 |
| Overexpression of POFUT1 promotes malignant phenotype and mediates perineural invasion in head and neck squamous cell carcinoma N Barlak, G Kusdemir, R Gumus, B Gundogdu, MH Sahin, A Tatar, ... Cell biology international 47 (12), 1950-1963, 2023 | 1 | 2023 |
| Expression and prognostic value of ING3 in advanced laryngeal squamous cell carcinoma N Barlak, G Kuşdemir, R Gumus, A Şahin, B Gündoğdu, ÖF Karatas, ... The European Research Journal 9 (3), 517-528, 2023 | 1 | 2023 |
| Novel Schiff Bases: Synthesis, Characterization, Bioactivity, Cytotoxicity, and Computational Evaluations H Medetalibeyoğlu, S Manap, M Alkan, M Beytur, N Barlak, OF Karatas, ... Polycyclic Aromatic Compounds, 1-19, 2024 | | 2024 |
| Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer HO Caglar, A Aytatli, N Barlak, E Aydin Karatas, A Tatar, A Sahin, ... Head & Neck, 2024 | | 2024 |
